Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesPractice ManagementACR's Ted Burnes talks advocacy in radiology with AuntMinnieTed Burnes from the American College of Radiology spoke with AuntMinnie on achievements in advocacy and what 2026 may bring.Molecular ImagingPiB-PET/CT detects subtypes in cardiac amyloidosisPractice ManagementHPI: 13.5B mL of contrast media administered from 2011 to 2024UltrasoundAI ultrasound tool could reduce unnecessary biopsies by 60%RSNA 20253D CNN model estimates MACE risk from chest CT